25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Anteo Diagnostics Ltd
Buy, Hold or Sell?

Let's analyze Anteo Diagnostics Ltd together

I guess you are interested in Anteo Diagnostics Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Anteo Diagnostics Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Anteo Diagnostics Ltd

I send you an email if I find something interesting about Anteo Diagnostics Ltd.

1. Quick Overview

1.1. Quick analysis of Anteo Diagnostics Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Anteo Diagnostics Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
20.0%

What is your share worth?

Current worth
A$0.00
Expected worth in 1 year
A$0.01
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
A$0.00
Return On Investment
25.5%

For what price can you sell your share?

Current Price per Share
A$0.02
Expected price per share
A$0.016 - A$0.018
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Anteo Diagnostics Ltd (5 min.)




Live pricePrice per Share (EOD)
A$0.02
Intrinsic Value Per Share
A$-0.04 - A$-0.03
Total Value Per Share
A$-0.04 - A$-0.02

2.2. Growth of Anteo Diagnostics Ltd (5 min.)




Is Anteo Diagnostics Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$3.3m$1.4m$1.8m55.2%

How much money is Anteo Diagnostics Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$5.5m-$7.9m$2.3m42.5%
Net Profit Margin-1,928.9%-3,460.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Anteo Diagnostics Ltd (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#714 / 931

Most Revenue
#595 / 931

Most Profit
#433 / 931

Most Efficient
#758 / 931
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Anteo Diagnostics Ltd?

Welcome investor! Anteo Diagnostics Ltd's management wants to use your money to grow the business. In return you get a share of Anteo Diagnostics Ltd.

First you should know what it really means to hold a share of Anteo Diagnostics Ltd. And how you can make/lose money.

Speculation

The Price per Share of Anteo Diagnostics Ltd is A$0.017. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Anteo Diagnostics Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Anteo Diagnostics Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.00. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Anteo Diagnostics Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-12.1%0.00-12.1%0.00-17.3%0.00-11.3%0.00-9.6%
Usd Book Value Change Per Share0.004.0%0.004.0%0.00-13.6%0.000.3%0.00-0.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.006.4%0.003.2%
Usd Total Gains Per Share0.004.0%0.004.0%0.00-13.6%0.006.7%0.002.9%
Usd Price Per Share0.01-0.01-0.03-0.05-0.04-
Price to Earnings Ratio-6.15--6.15--8.62--32.14--24.80-
Price-to-Total Gains Ratio18.66-18.66--10.93-23.81-14.53-
Price to Book Ratio10.30-10.30-45.87-24.10-19.31-
Price-to-Total Gains Ratio18.66-18.66--10.93-23.81-14.53-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0106658
Number of shares93757
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (93757 shares)63.69106.50
Gains per Year (93757 shares)254.78425.99
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1025524540719416
2051050081537842
307647551222561268
40101910101629751694
50127412652037932120
601529152024441122546
701783177528521302972
802038203032591493398
902293228536661683824
1002548254040741864250

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%1.024.01.03.8%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%2.03.00.040.0%4.06.00.040.0%11.015.00.042.3%
Dividend per Share0.00.01.00.0%0.00.03.00.0%2.00.03.040.0%2.00.08.020.0%7.00.019.026.9%
Total Gains per Share1.00.00.0100.0%1.02.00.033.3%3.02.00.060.0%5.05.00.050.0%13.013.00.050.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Anteo Diagnostics Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0010.0010%-0.004+441%0.000+1268%0.000+106%
Book Value Per Share--0.0020.0020%0.001+123%0.003-40%0.003-33%
Current Ratio--3.0413.0410%1.741+75%7.399-59%7.041-57%
Debt To Asset Ratio--0.4340.4340%0.557-22%0.294+48%0.338+28%
Debt To Equity Ratio--0.7680.7680%1.256-39%0.520+48%1.120-31%
Dividend Per Share----0%-0%0.002-100%0.001-100%
Enterprise Value--55596918.35455596918.3540%108757648.710-49%224054274.419-75%150022476.187-63%
Eps---0.003-0.0030%-0.005+42%-0.003-6%-0.003-21%
Ev To Ebitda Ratio---4.805-4.8050%-7.321+52%-28.493+493%-23.436+388%
Ev To Sales Ratio--120.759120.7590%297.376-59%329.368-63%233.016-48%
Free Cash Flow Per Share---0.003-0.0030%-0.003+16%-0.003-6%-0.002-27%
Free Cash Flow To Equity Per Share--0.0010.0010%-0.003+420%0.000+1439%-0.001+166%
Gross Profit Margin--1.0691.0690%1.138-6%1.140-6%1.149-7%
Intrinsic Value_10Y_max---0.026--------
Intrinsic Value_10Y_min---0.040--------
Intrinsic Value_1Y_max---0.002--------
Intrinsic Value_1Y_min---0.004--------
Intrinsic Value_3Y_max---0.007--------
Intrinsic Value_3Y_min---0.011--------
Intrinsic Value_5Y_max---0.012--------
Intrinsic Value_5Y_min---0.019--------
Market Cap45990099.456-19%54647059.35454647059.3540%109023588.710-50%218209495.419-75%153255243.187-64%
Net Profit Margin---19.289-19.2890%-34.601+79%-17.068-12%-11.552-40%
Operating Margin---27.391-27.3910%-43.350+58%-21.912-20%-13.859-49%
Operating Ratio--26.47126.4710%34.777-24%19.471+36%13.414+97%
Pb Ratio8.668-19%10.29910.2990%45.874-78%24.097-57%19.309-47%
Pe Ratio-5.179+16%-6.154-6.1540%-8.616+40%-32.137+422%-24.803+303%
Price Per Share0.017-19%0.0200.0200%0.040-50%0.081-75%0.057-64%
Price To Free Cash Flow Ratio-6.067+16%-7.209-7.2090%-12.426+72%-40.089+456%-33.009+358%
Price To Total Gains Ratio15.700-19%18.65518.6550%-10.926+159%23.815-22%14.533+28%
Quick Ratio--2.9182.9180%1.617+80%7.260-60%6.550-55%
Return On Assets---0.947-0.9470%-2.360+149%-1.014+7%-0.751-21%
Return On Equity---1.674-1.6740%-5.325+218%-1.827+9%-1.304-22%
Total Gains Per Share--0.0010.0010%-0.004+441%0.002-40%0.001+35%
Usd Book Value--3328936.0903328936.0900%1491072.566+123%5566392.682-40%4950319.134-33%
Usd Book Value Change Per Share--0.0010.0010%-0.002+441%0.000+1268%0.000+106%
Usd Book Value Per Share--0.0010.0010%0.001+123%0.002-40%0.002-33%
Usd Dividend Per Share----0%-0%0.001-100%0.001-100%
Usd Enterprise Value--34881506.57534881506.5750%68234548.801-49%140571651.770-75%94124101.560-63%
Usd Eps---0.002-0.0020%-0.003+42%-0.002-6%-0.002-21%
Usd Free Cash Flow---4755721.488-4755721.4880%-5504809.482+16%-4474632.234-6%-3490367.992-27%
Usd Free Cash Flow Per Share---0.002-0.0020%-0.002+16%-0.002-6%-0.001-27%
Usd Free Cash Flow To Equity Per Share--0.0010.0010%-0.002+420%0.000+1439%0.000+166%
Usd Market Cap28854188.399-19%34285565.03834285565.0380%68401399.557-50%136904637.426-75%96152339.576-64%
Usd Price Per Share0.011-19%0.0130.0130%0.025-50%0.051-75%0.036-64%
Usd Profit---5571636.366-5571636.3660%-7939280.214+42%-5219180.989-6%-4169046.900-25%
Usd Revenue--288853.078288853.0780%229455.238+26%349394.794-17%588097.405-51%
Usd Total Gains Per Share--0.0010.0010%-0.002+441%0.001-40%0.001+35%
 EOD+2 -6MRQTTM+0 -0YOY+29 -95Y+9 -3110Y+11 -29

3.3 Fundamental Score

Let's check the fundamental score of Anteo Diagnostics Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.179
Price to Book Ratio (EOD)Between0-18.668
Net Profit Margin (MRQ)Greater than0-19.289
Operating Margin (MRQ)Greater than0-27.391
Quick Ratio (MRQ)Greater than12.918
Current Ratio (MRQ)Greater than13.041
Debt to Asset Ratio (MRQ)Less than10.434
Debt to Equity Ratio (MRQ)Less than10.768
Return on Equity (MRQ)Greater than0.15-1.674
Return on Assets (MRQ)Greater than0.05-0.947
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Anteo Diagnostics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.107
Ma 20Greater thanMa 500.017
Ma 50Greater thanMa 1000.018
Ma 100Greater thanMa 2000.021
OpenGreater thanClose0.017
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Anteo Diagnostics Ltd

AnteoTech Limited develops, manufactures, commercializes, and distributes products for clean energy technology and life science markets primarily in Australia, Asia, Europe, North America, and Latin America. Its products include AnteoBind, s an activation technology that offers an alternative to conventionally used chemistries for the life sciences industry; AnteoBind NXT solution for the development of diagnostic tests; AnteoBind Micro and Micro Kit , a micro-particle-based assay development and bioseparation; AnteoBind Sub-Micron, Particle-based assay development and bioseparation; AnteoBind Biosensor, a planar solid phase assay development; Activation Kit Multiplex Microspheres, an immunoassay development; and Nano Kit, a nanoparticle-based lateral flow assay development and bioseparation. The company also offers AnteoX, an additive that reinforces battery binders that enhance performance of silicon containing anodes; and Ultranode, an ultra-high silicon anode design to offer high performance for lithium-ion batteries. In addition, it provides contract services. The company was formerly known as Anteo Diagnostics Limited and changed its name to AnteoTech Limited in November 2019. AnteoTech Limited is headquartered in Eight Mile Plains, Australia.

Fundamental data was last updated by Penke on 2025-01-24 09:02:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Anteo Diagnostics Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Anteo Diagnostics Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -1,928.9% means that $-19.29 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Anteo Diagnostics Ltd:

  • The MRQ is -1,928.9%. The company is making a huge loss. -2
  • The TTM is -1,928.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,928.9%TTM-1,928.9%0.0%
TTM-1,928.9%YOY-3,460.1%+1,531.2%
TTM-1,928.9%5Y-1,706.8%-222.1%
5Y-1,706.8%10Y-1,155.2%-551.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,928.9%-101.1%-1,827.8%
TTM-1,928.9%-211.5%-1,717.4%
YOY-3,460.1%-207.4%-3,252.7%
5Y-1,706.8%-340.4%-1,366.4%
10Y-1,155.2%-486.1%-669.1%
4.3.1.2. Return on Assets

Shows how efficient Anteo Diagnostics Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Anteo Diagnostics Ltd to the Biotechnology industry mean.
  • -94.7% Return on Assets means that Anteo Diagnostics Ltd generated $-0.95 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Anteo Diagnostics Ltd:

  • The MRQ is -94.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -94.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-94.7%TTM-94.7%0.0%
TTM-94.7%YOY-236.0%+141.3%
TTM-94.7%5Y-101.4%+6.8%
5Y-101.4%10Y-75.1%-26.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-94.7%-12.3%-82.4%
TTM-94.7%-12.3%-82.4%
YOY-236.0%-11.8%-224.2%
5Y-101.4%-13.2%-88.2%
10Y-75.1%-15.2%-59.9%
4.3.1.3. Return on Equity

Shows how efficient Anteo Diagnostics Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Anteo Diagnostics Ltd to the Biotechnology industry mean.
  • -167.4% Return on Equity means Anteo Diagnostics Ltd generated $-1.67 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Anteo Diagnostics Ltd:

  • The MRQ is -167.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -167.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-167.4%TTM-167.4%0.0%
TTM-167.4%YOY-532.5%+365.1%
TTM-167.4%5Y-182.7%+15.3%
5Y-182.7%10Y-130.4%-52.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-167.4%-15.9%-151.5%
TTM-167.4%-16.7%-150.7%
YOY-532.5%-15.1%-517.4%
5Y-182.7%-19.2%-163.5%
10Y-130.4%-20.6%-109.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Anteo Diagnostics Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Anteo Diagnostics Ltd is operating .

  • Measures how much profit Anteo Diagnostics Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Anteo Diagnostics Ltd to the Biotechnology industry mean.
  • An Operating Margin of -2,739.1% means the company generated $-27.39  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Anteo Diagnostics Ltd:

  • The MRQ is -2,739.1%. The company is operating very inefficient. -2
  • The TTM is -2,739.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-2,739.1%TTM-2,739.1%0.0%
TTM-2,739.1%YOY-4,335.0%+1,595.9%
TTM-2,739.1%5Y-2,191.2%-547.9%
5Y-2,191.2%10Y-1,385.9%-805.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2,739.1%-197.4%-2,541.7%
TTM-2,739.1%-314.9%-2,424.2%
YOY-4,335.0%-216.9%-4,118.1%
5Y-2,191.2%-357.2%-1,834.0%
10Y-1,385.9%-481.3%-904.6%
4.3.2.2. Operating Ratio

Measures how efficient Anteo Diagnostics Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 26.47 means that the operating costs are $26.47 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Anteo Diagnostics Ltd:

  • The MRQ is 26.471. The company is inefficient in keeping operating costs low. -1
  • The TTM is 26.471. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ26.471TTM26.4710.000
TTM26.471YOY34.777-8.306
TTM26.4715Y19.471+7.000
5Y19.47110Y13.414+6.057
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ26.4712.160+24.311
TTM26.4713.241+23.230
YOY34.7773.257+31.520
5Y19.4714.740+14.731
10Y13.4146.433+6.981
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Anteo Diagnostics Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Anteo Diagnostics Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.04 means the company has $3.04 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Anteo Diagnostics Ltd:

  • The MRQ is 3.041. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.041. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.041TTM3.0410.000
TTM3.041YOY1.741+1.300
TTM3.0415Y7.399-4.358
5Y7.39910Y7.041+0.359
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0413.613-0.572
TTM3.0413.864-0.823
YOY1.7414.600-2.859
5Y7.3995.971+1.428
10Y7.0416.216+0.825
4.4.3.2. Quick Ratio

Measures if Anteo Diagnostics Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Anteo Diagnostics Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 2.92 means the company can pay off $2.92 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Anteo Diagnostics Ltd:

  • The MRQ is 2.918. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.918. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.918TTM2.9180.000
TTM2.918YOY1.617+1.301
TTM2.9185Y7.260-4.343
5Y7.26010Y6.550+0.710
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9183.042-0.124
TTM2.9183.360-0.442
YOY1.6174.358-2.741
5Y7.2605.955+1.305
10Y6.5506.492+0.058
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Anteo Diagnostics Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Anteo Diagnostics Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Anteo Diagnostics Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.43 means that Anteo Diagnostics Ltd assets are financed with 43.4% credit (debt) and the remaining percentage (100% - 43.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Anteo Diagnostics Ltd:

  • The MRQ is 0.434. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.434. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.434TTM0.4340.000
TTM0.434YOY0.557-0.122
TTM0.4345Y0.294+0.141
5Y0.29410Y0.338-0.044
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4340.341+0.093
TTM0.4340.341+0.093
YOY0.5570.316+0.241
5Y0.2940.363-0.069
10Y0.3380.384-0.046
4.5.4.2. Debt to Equity Ratio

Measures if Anteo Diagnostics Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Anteo Diagnostics Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 76.8% means that company has $0.77 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Anteo Diagnostics Ltd:

  • The MRQ is 0.768. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.768. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.768TTM0.7680.000
TTM0.768YOY1.256-0.488
TTM0.7685Y0.520+0.248
5Y0.52010Y1.120-0.601
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7680.385+0.383
TTM0.7680.428+0.340
YOY1.2560.391+0.865
5Y0.5200.450+0.070
10Y1.1200.493+0.627
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Anteo Diagnostics Ltd generates.

  • Above 15 is considered overpriced but always compare Anteo Diagnostics Ltd to the Biotechnology industry mean.
  • A PE ratio of -6.15 means the investor is paying $-6.15 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Anteo Diagnostics Ltd:

  • The EOD is -5.179. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.154. Based on the earnings, the company is expensive. -2
  • The TTM is -6.154. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.179MRQ-6.154+0.975
MRQ-6.154TTM-6.1540.000
TTM-6.154YOY-8.616+2.462
TTM-6.1545Y-32.137+25.983
5Y-32.13710Y-24.803-7.334
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.179-2.346-2.833
MRQ-6.154-2.881-3.273
TTM-6.154-3.288-2.866
YOY-8.616-3.355-5.261
5Y-32.137-6.132-26.005
10Y-24.803-6.692-18.111
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Anteo Diagnostics Ltd:

  • The EOD is -6.067. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -7.209. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -7.209. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.067MRQ-7.209+1.142
MRQ-7.209TTM-7.2090.000
TTM-7.209YOY-12.426+5.216
TTM-7.2095Y-40.089+32.880
5Y-40.08910Y-33.009-7.081
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.067-3.046-3.021
MRQ-7.209-3.650-3.559
TTM-7.209-3.891-3.318
YOY-12.426-4.493-7.933
5Y-40.089-8.265-31.824
10Y-33.009-9.294-23.715
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Anteo Diagnostics Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 10.30 means the investor is paying $10.30 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Anteo Diagnostics Ltd:

  • The EOD is 8.668. Based on the equity, the company is overpriced. -1
  • The MRQ is 10.299. Based on the equity, the company is expensive. -2
  • The TTM is 10.299. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD8.668MRQ10.299-1.632
MRQ10.299TTM10.2990.000
TTM10.299YOY45.874-35.575
TTM10.2995Y24.097-13.798
5Y24.09710Y19.309+4.788
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD8.6681.937+6.731
MRQ10.2992.254+8.045
TTM10.2992.463+7.836
YOY45.8742.469+43.405
5Y24.0973.763+20.334
10Y19.3094.449+14.860
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Anteo Diagnostics Ltd.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-06-302021-06-302022-06-302023-06-302024-06-30
Current Deferred Revenue -135-142-27720-258-390-6481,7301,082



5.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets9,381
Total Liabilities4,075
Total Stockholder Equity5,306
 As reported
Total Liabilities 4,075
Total Stockholder Equity+ 5,306
Total Assets = 9,381

Assets

Total Assets9,381
Total Current Assets5,454
Long-term Assets3,927
Total Current Assets
Cash And Cash Equivalents 5,025
Net Receivables 207
Other Current Assets 222
Total Current Assets  (as reported)5,454
Total Current Assets  (calculated)5,454
+/-0
Long-term Assets
Property Plant Equipment 3,897
Long Term Investments 30
Long-term Assets  (as reported)3,927
Long-term Assets  (calculated)3,927
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,793
Long-term Liabilities2,282
Total Stockholder Equity5,306
Total Current Liabilities
Short-term Debt 623
Accounts payable 517
Other Current Liabilities 653
Total Current Liabilities  (as reported)1,793
Total Current Liabilities  (calculated)1,793
+/-0
Long-term Liabilities
Capital Lease Obligations 2,311
Long-term Liabilities  (as reported)2,282
Long-term Liabilities  (calculated)2,311
+/- 29
Total Stockholder Equity
Common Stock99,817
Retained Earnings -99,897
Accumulated Other Comprehensive Income 5,386
Total Stockholder Equity (as reported)5,306
Total Stockholder Equity (calculated)5,306
+/-0
Other
Capital Stock99,817
Cash and Short Term Investments 5,025
Common Stock Shares Outstanding 2,237,397
Current Deferred Revenue1,082
Liabilities and Stockholders Equity 9,381
Net Debt -2,715
Net Invested Capital 5,306
Net Working Capital 3,661
Property Plant and Equipment Gross 7,985
Short Long Term Debt Total 2,311



5.3. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-301999-06-30
> Total Assets 
7,865
7,933
11,527
7,971
5,037
3,435
732
1,909
1,959
3,472
1,332
1,723
7,285
5,211
3,275
7,667
6,005
52,528
45,814
4,470
4,768
3,909
23,675
15,264
5,362
9,381
9,3815,36215,26423,6753,9094,7684,47045,81452,5286,0057,6673,2755,2117,2851,7231,3323,4721,9591,9097323,4355,0377,97111,5277,9337,865
   > Total Current Assets 
6,313
5,868
6,470
5,172
3,317
2,567
542
1,428
1,483
3,260
1,031
1,481
7,003
4,929
3,024
7,314
5,469
16,343
45,433
4,191
4,456
3,378
21,789
10,826
3,142
5,454
5,4543,14210,82621,7893,3784,4564,19145,43316,3435,4697,3143,0244,9297,0031,4811,0313,2601,4831,4285422,5673,3175,1726,4705,8686,313
       Cash And Cash Equivalents 
6,310
5,601
5,568
3,764
1,247
422
297
1,422
1,281
3,121
953
1,426
6,864
4,883
2,621
7,071
5,174
3,760
955
3,329
4,276
3,215
21,392
10,103
2,720
5,025
5,0252,72010,10321,3923,2154,2763,3299553,7605,1747,0712,6214,8836,8641,4269533,1211,2811,4222974221,2473,7645,5685,6016,310
       Short-term Investments 
0
0
0
5
6
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
00000000000010000000065000
       Net Receivables 
0
46
92
514
870
624
1
128
173
138
76
53
137
43
402
113
111
6,594
107
4
7
73
242
469
198
207
20719846924273741076,594111113402431375376138173128162487051492460
       Other Current Assets 
3
43
154
118
157
78
9
6
28
1
2
2
2
3
2
130
185
919
44,372
859
173
91
155
254
225
222
2222252541559117385944,372919185130232221286978157118154433
   > Long-term Assets 
1,553
2,064
5,058
2,799
1,720
868
190
481
476
212
302
242
282
283
251
353
537
36,185
381
279
312
531
1,886
4,438
2,220
3,927
3,9272,2204,4381,88653131227938136,1855373532512832822423022124764811908681,7202,7995,0582,0641,553
       Property Plant Equipment 
1,352
292
4,439
2,277
1,273
737
123
481
476
212
302
242
282
283
251
353
537
22,919
381
279
312
531
1,886
4,015
2,220
3,897
3,8972,2204,0151,88653131227938122,9195373532512832822423022124764811237371,2732,2774,4392921,352
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,912
0
0
0
0
0
0
0
0
000000009,91200000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
8
0
0
0
0
0
0
30
300000008800000000000000000
       Intangible Assets 
201
288
383
456
447
131
67
0
0
0
0
0
0
0
0
0
0
3,347
13,240
0
0
0
0
0
0
0
000000013,2403,347000000000067131447456383288201
       Other Assets 
0
1,484
3,710
1,269
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000001,2693,7101,4840
> Total Liabilities 
11
618
1,328
1,598
1,582
1,327
205
317
409
462
300
329
394
439
500
566
692
38,641
38,711
468
533
700
2,561
2,909
2,986
4,075
4,0752,9862,9092,56170053346838,71138,6416925665004393943293004624093172051,3271,5821,5981,32861811
   > Total Current Liabilities 
11
593
1,156
1,435
1,443
1,272
205
317
409
462
300
329
394
439
500
483
598
17,159
38,675
450
347
623
1,084
1,616
1,804
1,793
1,7931,8041,6161,08462334745038,67517,1595984835004393943293004624093172051,2721,4431,4351,15659311
       Short-term Debt 
0
11
48
190
91
115
37
0
0
0
0
0
0
0
0
0
0
269
226
0
135
135
277
258
648
623
62364825827713513502262690000000000371159119048110
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,266
834
0
0
0
0
0
0
0
000000083411,26600000000000000000
       Accounts payable 
11
556
723
350
699
629
58
70
35
102
33
72
48
90
144
165
226
3,118
367
153
130
61
390
704
533
517
517533704390611301533673,1182261651449048723310235705862969935072355611
       Other Current Liabilities 
0
26
385
894
653
528
110
246
374
360
267
257
346
349
355
318
372
12,571
38,081
297
218
427
417
655
624
653
65362465541742721829738,08112,571372318355349346257267360374246110528653894385260
   > Long-term Liabilities 
0
25
172
164
138
55
0
0
0
0
0
0
0
0
0
83
95
23,546
36
18
185
77
1,477
1,293
1,181
2,282
2,2821,1811,2931,47777185183623,546958300000000055138164172250
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,089
0
0
0
0
1,005
776
659
0
06597761,005000015,08900000000000000000
       Other Liabilities 
0
0
0
7
0
32
0
0
0
0
0
0
0
0
0
83
65
10,973
36
18
185
77
472
517
523
0
052351747277185183610,97365830000000003207000
> Total Stockholder Equity
7,854
7,315
10,199
6,373
3,456
2,108
527
1,592
1,550
3,010
1,033
1,394
6,891
4,773
2,776
7,101
5,313
13,887
7,103
4,002
4,235
3,209
21,114
12,355
2,377
5,306
5,3062,37712,35521,1143,2094,2354,0027,10313,8875,3137,1012,7764,7736,8911,3941,0333,0101,5501,5925272,1083,4566,37310,1997,3157,854
   Common Stock
7,873
7,882
12,168
17,506
17,535
19,063
19,126
16,746
18,359
21,536
21,536
24,153
31,859
32,121
31,969
38,658
41,098
55,100
58,738
59,062
62,421
64,292
86,209
87,454
89,302
99,817
99,81789,30287,45486,20964,29262,42159,06258,73855,10041,09838,65831,96932,12131,85924,15321,53621,53618,35916,74619,12619,06317,53517,50612,1687,8827,873
   Retained Earnings -99,897-91,016-78,362-67,645-61,429-58,356-55,847-52,396-43,765-37,009-32,012-29,522-27,348-24,968-22,744-20,504-18,526-16,809-15,154-18,599-16,955-14,080-11,133-1,969-568-19
   Capital Surplus 00000000000000000000000000
   Treasury Stock00000000000000000000000000
   Other Stockholders Equity 
0
71
188
358
708
1,022
747
1,129
-212
1,322
-70
1,397
-109
-313
1,808
2,039
-844
2,043
3,195
0
2,331
-2,862
-18,564
-9,093
0
0
00-9,093-18,564-2,8622,33103,1952,043-8442,0391,808-313-1091,397-701,322-2121,1297471,022708358188710



5.4. Balance Sheets

Currency in AUD. All numbers in thousands.




5.5. Cash Flows

Currency in AUD. All numbers in thousands.